Bakr Jundi

Anesthesiology

2727 Paces Ferry Rd Se
Suite 1 1100
Atlanta, GA 30339

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

AI-assisted human clinical reasoning in the ICU: beyond "to err is human".

AI-assisted human clinical reasoning in the ICU: beyond "to err is human".

Journal: Frontiers in artificial intelligence

Published: October 05, 2024

Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Emphysema.

Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Emphysema.

Journal: American journal of respiratory cell and molecular biology

Published: August 01, 2023

Small-Molecule Activation of Protein Phosphatase 2A Counters Bleomycin-Induced Fibrosis in Mice.

Small-Molecule Activation of Protein Phosphatase 2A Counters Bleomycin-Induced Fibrosis in Mice.

Journal: ACS pharmacology & translational science

Published: June 12, 2023

Correction: Fully-automated and field-deployable blood leukocyte separation platform using multi-dimensional double spiral (MDDS) inertial microfluidics.

Correction: Fully-automated and field-deployable blood leukocyte separation platform using multi-dimensional double spiral (MDDS) inertial microfluidics.

Journal: Lab on a chip

Published: April 06, 2023

The Relationship of Cholesterol Responses to Mitochondrial Dysfunction and Lung Inflammation in Chronic Obstructive Pulmonary Disease.

The Relationship of Cholesterol Responses to Mitochondrial Dysfunction and Lung Inflammation in Chronic Obstructive Pulmonary Disease.

Journal: Medicina (Kaunas, Lithuania)

Published: December 06, 2022

Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.

Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.

Journal: American journal of respiratory cell and molecular biology

Published: May 04, 2022

Increased Neutrophil-Subset Associated With Severity/Mortality In ARDS And COVID19-ARDS Expresses The Dual Endothelin-1/VEGFsignal-Peptide Receptor (DEspR): An Actionable Therapeutic Target.

Increased Neutrophil-Subset Associated With Severity/Mortality In ARDS And COVID19-ARDS Expresses The Dual Endothelin-1/VEGFsignal-Peptide Receptor (DEspR): An Actionable Therapeutic Target.

Journal: Research square

Published: September 21, 2021

A targetable 'rogue' neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS.

A targetable 'rogue' neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS.

Journal: Scientific reports

Published: August 25, 2021

Fully Automated, Sample-to-Answer Leukocyte Functional Assessment Platform for Continuous Sepsis Monitoring via Microliters of Blood.

Fully Automated, Sample-to-Answer Leukocyte Functional Assessment Platform for Continuous Sepsis Monitoring via Microliters of Blood.

Journal: ACS sensors

Published: June 29, 2021

The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases.

The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases.

Journal: Pulmonary medicine

Published: April 28, 2021

Inflammation resolution circuits are uncoupled in acute sepsis and correlate with clinical severity.

Inflammation resolution circuits are uncoupled in acute sepsis and correlate with clinical severity.

Journal: JCI insight

Published: March 31, 2021

ADAM17: A Therapeutic Target for Patients with Emphysema?

ADAM17: A Therapeutic Target for Patients with Emphysema?

Journal: American journal of respiratory cell and molecular biology

Published: February 01, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026